Scientific article
English

Topical iontophoresis of buflomedil hydrochloride increases drug bioavailability in the mucosa: A targeted approach to treat oral submucous fibrosis

Published inInternational Journal of Pharmaceutics, vol. 569, 118610
Publication date2019
Abstract

The aim was to investigate the effect of constant current iontophoresis on the delivery and biodistribution of buflomedil hydrochloride (BUF) in the buccal mucosa. Quantification was by UHPLC-MS/MS; in addition to total delivery, the amounts present in the epithelia and the lamina propria (the target tissue) were also determined. Two-compartment vertical diffusion cells were used to investigate the effect of current density (0.5, 1 and 2 mA/cm2), application time (5, 10 and 20 min) and concentration (5, 10 and 20 mM) on iontophoretic delivery of BUF from aqueous solutions. In contrast to passive delivery, iontophoresis for 10 min at 1 mA/cm2 resulted in statistically equivalent transport from a 20 mM solution and a 2% HEC hydrogel (with equivalent BUF loading; 20 µmol). BUF delivery from the hydrogel using diffusion cells and a new coplanar "side-by-side" set-up was statistically equivalent (304.2 ± 28.9 and 278.2 ± 40.3 µg/cm2) - passive delivery was also similar. Iontophoresis (10 min at 1 mA/cm2) using a thin film (20 µmol BUF) was superior to the passive control (323.3 ± 5.9 and 24.8 ± 5.9 µg/cm2). Concentrations in the LP were ~700-fold > IC50 to block collagen production, potentially providing a new therapeutic strategy for oral submucous fibrosis.

Keywords
  • Administration, Cutaneous
  • Animals
  • Biological Availability
  • Esophageal Mucosa/metabolism
  • Hydrogels/administration & dosage
  • Iontophoresis
  • Oral Submucous Fibrosis/drug therapy
  • Pyrrolidines/administration & dosage
  • Swine
  • Vasodilator Agents/administration & dosage
Citation (ISO format)
TYAGI, Vasundhara et al. Topical iontophoresis of buflomedil hydrochloride increases drug bioavailability in the mucosa: A targeted approach to treat oral submucous fibrosis. In: International Journal of Pharmaceutics, 2019, vol. 569, p. 118610. doi: 10.1016/j.ijpharm.2019.118610
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0378-5173
257views
1downloads

Technical informations

Creation09/07/2020 16:38:00
First validation09/07/2020 16:38:00
Update time15/03/2023 22:18:00
Status update15/03/2023 22:17:59
Last indexation02/10/2024 12:33:22
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack